Aclaris Therapeutics (ACRS) logo

ACRS earnings date, and what happened the last 4 times

Next report

Thu Nov 5

Quality Score today -4

Before the open, in 10 days. Expected: the company has not confirmed it.

ACRS closed higher after 2 of its last 4 reports. On average it closed -1.9% the session after a report.

The moment ACRS reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when ACRS reports, with its figures

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

What happened after ACRS's last 4 reports

ACRS's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 6, 20262026 · Before open9estimated-0.3%-4.3%
May 7, 20262026 · Before open7estimated-2.4%+1.7%
Feb 26, 20262026 · Before open0estimated-4.2%-5.4%
Nov 6, 20252025 · Before open-1estimated+1.3%+0.4%
  • Aug 6, 2026, before the open: that session ACRS opened -0.3% and closed -4.3%, and five sessions on it stood -8.2%. Its Quality Score going in was 9 (Average), estimated.
  • May 7, 2026, before the open: that session ACRS opened -2.4% and closed +1.7%, and five sessions on it stood +6.5%. Its Quality Score going in was 7 (Average), estimated.
  • Feb 26, 2026, before the open: that session ACRS opened -4.2% and closed -5.4%, and five sessions on it stood -6.3%. Its Quality Score going in was 0 (Below Average), estimated.
  • Nov 6, 2025, before the open: that session ACRS opened +1.3% and closed +0.4%, and five sessions on it stood +6.6%. Its Quality Score going in was -1 (Poor), estimated.

Across these 4 reports ACRS opened higher after 1 of 4 and closed higher after 2 of 4; on average it opened -1.4%, closed -1.9%, and stood -0.3% five sessions on. Its Quality Score is -4 today, against 9 going into its Aug 6, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: -5.4% after the Feb 26, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see ACRS's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about ACRS's earnings

As of Oct 26, 2026: Aclaris Therapeutics (ACRS): expected to report Thu Nov 5, before the open. ACRS closed higher after 2 of its last 4 reports. Its Quality Score is -4 (Poor). Scores as of 10:16 PM ET, 15 minutes behind.

When is ACRS's next earnings date?

Expected to report Thu Nov 5, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. ACRS closed higher after 2 of its last 4 reports. Past behavior, not a forecast.

Does ACRS report before or after the market?

ACRS is expected to report Thu Nov 5, before the open. Its last 4 reports came before the open.

How did ACRS stock react to its last earnings report?

Aug 6, 2026, before the open: that session ACRS opened -0.3% and closed -4.3%, and five sessions on it stood -8.2%.

Does ACRS stock usually go up after earnings?

ACRS closed higher after 2 of its last 4 reports. On average it closed -1.9% the session after a report, after opening -1.4%. Past behavior, not a forecast.

Aclaris Therapeutics' page has its Quality Score, its chart, and its insiders' trades. Everyone reporting beside it: next week's earnings.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.